ONCT - Oncternal Therapeutics Inc. (ONCT) CEO Dr. Jim Breitmeyer on Q4 2019 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT)
Q4 2019 Results Conference Call
March 16, 2020 04:30 PM ET
Company Participants
Richard Vincent - CFO
Dr. Jim Breitmeyer - President and CEO
Dr. Frank Hsu - Chief Medical Officer
Conference Call Participants
Hartaj Singh - Oppenheimer
Matt Kaplan - Ladenburg
Carl Byrnes - Northland Securities
Presentation
Operator
Greetings, ladies and gentlemen, and welcome to the Oncternal Therapeutics Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is